Amgen, Astellas provide new medicines in Japan

Amgen, Astellas to provide new medicines in Japan

7:00 AM, 30th May 2013
Amgen, Astellas to provide new medicines in Japan

TOKYO, JAPAN: Amgen Inc, the world’s largest biotechnology company, entered into a long-term collaboration with Astellas Pharma Inc and will form a joint venture with the Japanese drugmaker to provide new medicines in Japan. Amgen plans to expand its business into major Asian markets in 2015 and 2016 and called its lack of presence in Japan and China “a noticeable gap.” The JV takes a major step toward filling that gap.

Amgen and Astellas will establish a Tokyo-based joint venture to be called Amgen Astellas BioPharma KK that is expected to begin operating on 1 October 2013. Amgen will initially own 51 per cent of the joint venture and it will become fully owned by the US biotech as soon as 2020, said the companies in a statement. The companies will co-develop and sell five drugs currently in Amgen’s pipeline, with the first commercial launch in Japan potentially coming in 2016.

“This alliance reflects our long-term commitment to the Japan market and is an important step in our global expansion efforts. This alliance will help accelerate development and commercialization of Amgen medicines for patients in Japan,” said Robert Bradway, Chief Executive, Amgen.

© Reuters News

Read more mergers and acquisition news of chemical industry -



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Aesica appoints new Managing Director for API business unit

  NEWCASTLE, UK: Aesica has appointed Kevin Cook as new Managing Director of its active pharmaceutical ingredient (API) business unit. Kevin wil ...

Read more
Pesticides, industrial chemicals to join UN treaty watch list

  ROME, ITALY: United Nations experts have recommended that two pesticides, one severely hazardous pesticide formulation and three industrial ch ...

Read more
Lanxess opens new company in Dubai, Middle East

  The specialty chemicals group establishes new company with office in Dubai to target opportunities in the Middle East.   LEVERKUSEN, GE ...

Read more
Egypt to build world’s largest methanol plant

LONDON, UK: Egypt Japan Petrochemical Corporation SAE (EJPC) is constructing a methanol plant, termed to be the largest in the world. The plant comb ...

Read more
Solvay to acquire Rhodia for € 3.4 billion in all cash deal

  BRUSSELS, BELGIUM/PARIS, FRANCE: Solvay has agreed to acquire Rhodia for € 3.4 billion in an all cash deal. As per agreement, Solvay will ...

Read more
Calgon buys out Mitsubishi Chemical stake in Calgon Japan

  PITTSBURGH,US: Calgon Carbon Corporation announced it has completed the acquisition of Calgon Carbon Japan KK, the former joint venture betwee ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X